Login / Signup

Radiotherapy dose-volume parameters predict facial lymphedema after concurrent chemoradiation for nasopharyngeal carcinoma.

Donghyun KimJiho NamWontaek KimDahl ParkJihyeon JooHosang JeonYong Gan Ki
Published in: Radiation oncology (London, England) (2021)
Keeping mean dose to the level IV and level I-VII below 58.7 Gy and 58.6 Gy may reduce the likelihood of moderate/severe FL after CCRT for NPC.
Keyphrases
  • locally advanced
  • rectal cancer
  • early stage
  • radiation therapy
  • squamous cell carcinoma
  • high intensity
  • early onset
  • soft tissue
  • drug induced